Weitz & Luxenberg has filed a multidistrict litigation petition against twelve U.S. hotel chains for corporate malfeasance for failing to safeguard against constant sex trafficking…
Read MoreFirm News: Drugs & Devices: Page 15
Category: Drugs & Devices
Hydoxycut Recall
Weitz & Luxenberg P.C. would like to inform the public that the Food and Drug Administration (FDA) issued a warning on May 1, 2009 to immediately stop use of Hydroxycut dietary supplements by Iovate Health Sciences Inc. after reports of serious health problems in users taking the recommended doses. Iovate recalled 14 Hydroxycut products from…
Category: Drugs & Devices
$13.5 Million in Vioxx Trial
Weitz & Luxenberg client John McDarby, 77, and his wife were rewarded a $4.5 million dollar verdict and $9 million in punitive damages from a New Jersey jury in one of the first Vioxx trial cases against Merck. ”The verdict is a victory for the 100,000 Americans who had heart attacks from Vioxx,” said lawyer Robert Gordon.…